Free Trial

Expensify (EXFY) Competitors

Expensify logo
$2.22 0.00 (0.00%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$2.27 +0.05 (+2.25%)
As of 07/25/2025 06:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EXFY vs. CGNT, DOMO, VMEO, RDVT, PUBM, RZLV, WEAV, OSPN, DH, and CANG

Should you be buying Expensify stock or one of its competitors? The main competitors of Expensify include Cognyte Software (CGNT), Domo (DOMO), Vimeo (VMEO), Red Violet (RDVT), PubMatic (PUBM), Rezolve AI (RZLV), Weave Communications (WEAV), ONESPAN (OSPN), Definitive Healthcare (DH), and Cango (CANG). These companies are all part of the "computer software" industry.

Expensify vs. Its Competitors

Expensify (NASDAQ:EXFY) and Cognyte Software (NASDAQ:CGNT) are both small-cap computer software companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, institutional ownership, analyst recommendations and risk.

In the previous week, Expensify had 1 more articles in the media than Cognyte Software. MarketBeat recorded 3 mentions for Expensify and 2 mentions for Cognyte Software. Cognyte Software's average media sentiment score of 0.93 beat Expensify's score of 0.63 indicating that Cognyte Software is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Expensify
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cognyte Software
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cognyte Software has a net margin of -2.18% compared to Expensify's net margin of -6.66%. Cognyte Software's return on equity of -3.53% beat Expensify's return on equity.

Company Net Margins Return on Equity Return on Assets
Expensify-6.66% -7.60% -5.16%
Cognyte Software -2.18%-3.53%-1.56%

Expensify has higher earnings, but lower revenue than Cognyte Software. Cognyte Software is trading at a lower price-to-earnings ratio than Expensify, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Expensify$139.24M1.28-$10.06M-$0.09-24.67
Cognyte Software$350.63M1.91-$12.05M-$0.11-84.55

68.4% of Expensify shares are held by institutional investors. Comparatively, 72.9% of Cognyte Software shares are held by institutional investors. 12.3% of Expensify shares are held by insiders. Comparatively, 62.7% of Cognyte Software shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Expensify presently has a consensus target price of $4.00, suggesting a potential upside of 80.18%. Given Expensify's stronger consensus rating and higher probable upside, research analysts clearly believe Expensify is more favorable than Cognyte Software.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Expensify
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Cognyte Software
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Expensify has a beta of 1.75, indicating that its share price is 75% more volatile than the S&P 500. Comparatively, Cognyte Software has a beta of 1.65, indicating that its share price is 65% more volatile than the S&P 500.

Summary

Expensify and Cognyte Software tied by winning 8 of the 16 factors compared between the two stocks.

Get Expensify News Delivered to You Automatically

Sign up to receive the latest news and ratings for EXFY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EXFY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EXFY vs. The Competition

MetricExpensifyFinancial Transaction Services IndustryBusiness SectorNASDAQ Exchange
Market Cap$178.43M$34.25B$19.00B$9.50B
Dividend YieldN/A2.38%2.73%4.01%
P/E Ratio-24.6729.5429.5320.05
Price / Sales1.2812.8050.2790.07
Price / CashN/A19.0627.3958.56
Price / Book1.347.586.265.87
Net Income-$10.06M$1.11B$197.18M$258.55M
7 Day Performance4.72%-0.07%1.55%3.74%
1 Month Performance-10.12%-2.06%5.45%11.75%
1 Year Performance12.12%32.25%26.56%18.03%

Expensify Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EXFY
Expensify
2.581 of 5 stars
$2.22
flat
$4.00
+80.2%
+16.2%$178.43M$139.24M-24.67140News Coverage
Analyst Upgrade
CGNT
Cognyte Software
1.926 of 5 stars
$9.16
-0.2%
N/A+23.8%$661.48M$350.63M-83.271,623
DOMO
Domo
3.5391 of 5 stars
$15.81
-2.9%
$13.14
-16.9%
+89.3%$655.43M$317.04M-8.37920High Trading Volume
VMEO
Vimeo
3.8875 of 5 stars
$4.03
+2.0%
$7.35
+82.4%
+7.3%$650.74M$417.01M40.301,102Positive News
RDVT
Red Violet
0.8602 of 5 stars
$45.48
+0.1%
N/A+68.0%$634.02M$75.19M74.56140Positive News
PUBM
PubMatic
3.2683 of 5 stars
$12.79
+2.4%
$18.38
+43.7%
-42.4%$606.11M$291.26M159.891,049Insider Trade
RZLV
Rezolve AI
2.2313 of 5 stars
$2.70
-4.3%
$6.00
+122.2%
N/A$587.29M$190K0.00N/ANews Coverage
High Trading Volume
WEAV
Weave Communications
3.5627 of 5 stars
$7.81
+0.5%
$16.10
+106.3%
-24.3%$584.16M$204.31M-19.04890News Coverage
Upcoming Earnings
OSPN
ONESPAN
4.9201 of 5 stars
$14.91
-0.9%
$19.50
+30.8%
+5.2%$574.99M$243.18M10.14790Positive News
DH
Definitive Healthcare
1.2457 of 5 stars
$3.99
+3.9%
$5.10
+27.8%
-31.4%$570.79M$252.20M-0.91970
CANG
Cango
2.9917 of 5 stars
$5.02
-5.6%
N/A+157.5%$552.12M$110.21M-250.872,350Analyst Forecast
Analyst Revision
High Trading Volume

Related Companies and Tools


This page (NASDAQ:EXFY) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners